Table 1.
Tumor characteristics of 183 invasive breast cancer patients
| Characteristics | n | (%) |
|---|---|---|
| Age: median value 49 (range 24–83) | ||
| ≤ 49 years | 89 | (48.6) |
| > 49 years | 94 | (51.4) |
| Histological type | ||
| IDC | 116 | (90.7) |
| ILC | 10 | (5.5) |
| Other | 7 | (3.8) |
| Histological grade | ||
| G1 | 29 | (15.8) |
| G2 | 84 | (45.9) |
| G3 | 70 | (38.3) |
| Tumor size (cm) | ||
| ≤ 2 cm | 81 | (44.8) |
| > 2 cm | 100 | (55.2) |
| Unknown | 2 | |
| Lymph node status | ||
| Negative | 71 | (40.8) |
| Positive | 103 | (59.2) |
| Unknown | 9 | |
| Estrogen receptor | ||
| ER-negative (≤10%) | 53 | (29.0) |
| ER-positive (> 10%) | 130 | (71.0) |
| Unknown | 1 | |
| Progesterone receptor | ||
| PgR-negative (≤10%) | 76 | (41.5) |
| PgR-positive (> 10%) | 107 | (58.5) |
| MIB1 | ||
| Negative (≤20%) | 77 | (42.1) |
| Positive (> 20%) | 106 | (57.9) |
| HER2/neu | ||
| Negative (0,1+) | 78 | (50.6) |
| Positive (3+) | 76 | (49.4) |
| Unknown | 29 | |
| Triple negative tumors | 19 | (10.4) |
| Treatment | ||
| CT | 27 | (25.5) |
| HT | 16 | (15.1) |
| CT + HT | 63 | (39.6) |
| Unknown | 77 | |